Copaxone cuts risk of developing MS-

[cheerleader]

-In 481 patients presenting with a first flare and confirming MRI, but no definitive diagnosis.

In the interim analysis, the proportion of patients developing clinically definite multiple sclerosis (re: a second flare) was 43 percent in the placebo group compared with 25 percent in the Copaxone group, Teva said.

For those that received a clinical diagnosis of MS- the second attack was delayed to 722 days, vs. the 2nd attack average of 366 days in the placebo group-

http://www.reuters.com/article/health-S ... 03?sp=true

My husband was prescribed Copaxone after his first attack in March 2007. We're coming up on a year with no progression and no second attack.

best,
AC

[SunnyDay]

I was diagnosed in October of 07. I have not had another attack since the initial one. I don't remember having symptoms before my first attack either. So, this drug is working for me. I hope it continues to do so!